Atul Sharma Selected Research

Cytokines

1/2022	Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
12/2020	Cytokine profile in multiple myeloma.
4/2013	Synergistic effect of vascular endothelial growth factor and angiopoietin-2 on progression free survival in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atul Sharma Research Topics

Disease

29	Neoplasms (Cancer) 05/2022 - 07/2004
20	Multiple Myeloma 01/2022 - 05/2007
8	Inflammation (Inflammations) 01/2022 - 04/2016
7	Squamous Cell Carcinoma of Head and Neck 05/2022 - 04/2012
7	Head and Neck Neoplasms (Head and Neck Cancer) 05/2022 - 04/2012
7	Gallbladder Neoplasms (Gallbladder Cancer) 03/2021 - 02/2010
7	Infections 01/2021 - 01/2010
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 11/2005
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2014
6	Adenocarcinoma 03/2021 - 07/2004
5	Leukemia 01/2022 - 06/2012
5	Disease Progression 01/2022 - 01/2014
5	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 07/2003
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2006
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2022 - 03/2014
4	Carcinoma (Carcinomatosis) 06/2021 - 09/2014
4	COVID-19 11/2020 - 05/2020
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2014 - 11/2005
3	Mouth Neoplasms (Oral Cancer) 01/2022 - 08/2015
3	Nasopharyngeal Carcinoma 01/2022 - 01/2017
3	Bacterial Infections (Bacterial Infection) 01/2022 - 06/2018
3	Fever (Fevers) 10/2021 - 10/2010
3	Febrile Neutropenia 10/2021 - 06/2012
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 10/2016
3	Anemia 05/2018 - 04/2015
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2014 - 03/2010
2	Hand-Foot Syndrome 05/2022 - 10/2013
2	Hemorrhage 01/2022 - 02/2013
2	Pathologic Complete Response 01/2022 - 04/2013
2	Klebsiella Infections (Klebsiella Infection) 01/2022 - 04/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 07/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2021 - 02/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2021 - 02/2010
2	Postoperative Pain 01/2020 - 01/2015
2	Pain (Aches) 01/2020 - 01/2015
2	Albuminuria 11/2019 - 01/2019
2	Renal Insufficiency (Renal Failure) 01/2019 - 01/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 08/2018 - 08/2016
2	Pneumonia (Pneumonitis) 06/2018 - 04/2016
2	Residual Neoplasm 01/2017 - 11/2009
2	Sepsis (Septicemia) 04/2016 - 06/2014
2	Hypopharyngeal Neoplasms 03/2016 - 01/2014
2	Stomatitis 01/2016 - 04/2012
2	Mucositis 01/2016 - 04/2012
2	Lymphoma (Lymphomas) 09/2014 - 10/2009

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2012
7	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 01/2005
6	Gemcitabine FDA Link 06/2021 - 02/2010
6	Proteins (Proteins, Gene)FDA Link 12/2019 - 03/2014
5	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 01/2006
4	Capecitabine (Xeloda)FDA Link 05/2022 - 01/2014
4	Messenger RNA (mRNA)IBA 01/2022 - 07/2013
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2021 - 02/2010
3	Biological ProductsIBA 05/2022 - 01/2018
3	CytokinesIBA 01/2022 - 04/2013
3	ChemokinesIBA 01/2022 - 06/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 10/2010
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021 - 09/2012
3	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2015
3	Rituximab (Mabthera)FDA Link 01/2021 - 04/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 04/2013
3	hydroxide ionIBA 06/2019 - 05/2013
3	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 05/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 04/2017
3	Vitamin D FDA LinkGeneric 05/2018 - 01/2014
3	Hormones (Hormone)IBA 11/2017 - 04/2003
3	Etoposide (VP 16)FDA LinkGeneric 01/2013 - 07/2003
2	Diclofenac (SR 38)FDA LinkGeneric 05/2022 - 01/2020
2	Celecoxib (Celebrex)FDA Link 05/2022 - 03/2021
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 03/2021
2	Cetuximab (Erbitux)FDA Link 05/2022 - 01/2017
2	Bendamustine Hydrochloride FDA Link 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 05/2007
2	LigandsIBA 01/2022 - 06/2016
2	AntigensIBA 01/2022 - 03/2014
2	Antiviral Agents (Antivirals)IBA 07/2020 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 04/2020 - 10/2010
2	Cysteine (L-Cysteine)FDA Link 12/2019 - 10/2011
2	Cytochrome P-450 CYP3AIBA 06/2017 - 01/2017
2	C-Type Lectins (C-Type Lectin)IBA 04/2016 - 06/2014

Therapy/Procedure

41	Therapeutics 05/2022 - 07/2004
26	Drug Therapy (Chemotherapy) 01/2022 - 07/2003
9	Radiotherapy 05/2022 - 07/2004
9	Stem Cell Transplantation 01/2022 - 05/2007
4	Ligation 10/2022 - 01/2019
4	Combination Drug Therapy (Combination Chemotherapy) 10/2013 - 07/2003
3	Transplantation 10/2021 - 11/2019
3	Operative Surgical Procedures 03/2020 - 02/2016
3	Chemoradiotherapy 01/2017 - 10/2009
2	Length of Stay 01/2022 - 01/2013
2	Blood Transfusion (Blood Transfusions) 01/2022 - 04/2015
2	Glycemic Control 01/2022 - 01/2019
2	Neoadjuvant Therapy 08/2021 - 03/2021
2	Precision Medicine 06/2021 - 01/2017
2	Hematopoietic Stem Cell Transplantation 01/2020 - 04/2013
2	Extracorporeal Membrane Oxygenation 05/2016 - 12/2005
2	Stents 03/2016 - 02/2006
2	Aftercare (After-Treatment) 01/2015 - 05/2013